Sanofi, Glax­o­SmithK­line, Boehringer ac­cused of play­ing games, de­stroy­ing emails re­lat­ed to law­suit over con­t­a­m­i­nat­ed Zan­tac

A re­cent court fil­ing rais­es new ques­tions about how ma­jor phar­ma com­pa­nies like Sanofi, Glax­o­SmithK­line, and Boehringer In­gel­heim have dealt with a law­suit re­lat­ed to re­calls of cer­tain over-the-counter heart­burn drugs due to the pres­ence of a po­ten­tial­ly can­cer-caus­ing sub­stance found in them.

More than 70,000 peo­ple who took Sanofi’s Zan­tac and oth­er heart­burn drugs con­tain­ing ran­i­ti­dine, which have been re­called over the past two years, have sued the man­u­fac­tur­ers, in­clud­ing gener­ic drug­mak­ers, and oth­er re­tail­ers and dis­trib­u­tors as part of a con­sol­i­dat­ed suit be­fore US Dis­trict Court Judge Robin Rosen­berg in Flori­da.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER